Stories are generated from ORTEX data and reviewed by the ORTEX team. How we publish
Babcock & Wilcox sits at an odd intersection this week: nearly 20% of its free float is sold short, yet shares are available to borrow in abundance, cost to borrow is negligible, and an activist with a 25% stake is firmly on the register.
The positioning picture is dominated by that elevated short interest, but the lending market tells a different story. Short interest in BW has declined roughly 4% over the past week to around 21.9 million shares, or 19.8% of the free float. The month-on-month direction runs the other way: short interest has climbed 14% over the past 30 days, suggesting that a new wave of shorts built positions through September before a modest pullback this week. Despite all of that, borrow availability is extremely loose at 988%, meaning there are roughly ten shares available to lend for every one currently borrowed. Cost to borrow is just 0.46%, down 11% on the week. There is no squeeze pressure here. Shorts are not paying up, and the pool of available shares is far from strained.
Options traders, by contrast, are positioned in the opposite direction. The put/call ratio has collapsed to 0.21, well below its 20-day average of 0.38 and near the 52-week low of 0.10. That puts it about 1.6 standard deviations below its recent norm, signalling that call activity has swamped put buying in recent sessions. This is not a cautious market. Options positioning looks unambiguously bullish at a moment when the stock has fallen 3.4% on the week and 20.6% over the past month to close at $5.64. The divergence between elevated short interest and call-heavy options positioning is the sharpest tension in the BW setup right now.
The activist angle is one of the most newsworthy facts on this register. Bryant R. Riley, via B. Riley Securities and related entities, holds a 24.9% stake in BW as last disclosed in a Schedule 13D/A filed in February 2026, up from a prior 13.5%. That is an activist position of material size, and it sits at the top of the shareholder table. Galloway Capital Partners filed its own Schedule 13D in June 2025, disclosing 4.31%. Both are active filings with activist intent. As always with 13D/G disclosures, stakes are event-driven around the 5% threshold and positions may have changed since last filed. Alongside the activist holders, BlackRock reported 7.6% as of September 30, and Hood River Capital Management holds 9.2% as of June 30. The institutional register looks engaged rather than passive.
Insider activity from August adds another layer. CEO Kenneth Young made an open-market purchase of 7,000 shares at $9.65 on August 12, and director Philip Moeller bought 5,000 shares at $9.50 a day later. Neither is a huge dollar amount ($67,550 and $47,500 respectively), but both were discretionary purchases at prices well above where the stock trades today at $5.64. The 90-day net insider position is a modest positive at 12,000 shares worth roughly $115,050. Straight compensation mechanics (option exercises and tax withholdings) account for most of the volume in the period and carry no signal.
The Street is cautiously constructive, though the data is stale by about five weeks. Needham initiated coverage at the end of August with a Buy and a $20 target. That single fresh rating sets the consensus at Buy, with a mean target of $22 against a current price of $5.64. A gap of that size warrants a caveat: the $22 target is a Needham initiation and the data predates the 20% decline in the stock price. Earlier coverage from other firms carried targets in the $5 to $10 range, more consistent with where the stock has actually traded. On valuation, the EV/EBITDA multiple has compressed nearly a full turn over 30 days to 9.8x, and the trailing PE of 15x has dropped more than 7 points over the same period. BW's EPS surprise factor score ranks in the 95th percentile, the strongest reading in the snapshot, meaning the company has a track record of beating estimates. Its short score of 56.5 has drifted lower from a peak above 60 in late September, a small move toward less bearish short-side pressure.
The next earnings date is November 10. The last print in August produced a 1-day decline of 1.9%, followed by a 5-day gain of 5.9%, a pattern worth keeping in mind as the stock approaches that date from a much lower price. What to watch between now and then is whether short interest continues to unwind from its September peak, whether the call-heavy options positioning holds at these extremes, and whether Bryant Riley's team adds to or holds its stake as the share price tests levels well below the mid-August insider purchase prices.
See the live data behind this article on ORTEX.
Open BW on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.
